Ketamine Recruiting Phase 1 Trials for Major Depressive Disorder (MDD) Basic Science

IndicationsStatusPurposePhase
RecruitingBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT03977675The Role of HNKs in the Antidepressant Effect of Ketamine
NCT03367533Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response